Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3970957rdf:typepubmed:Citationlld:pubmed
pubmed-article:3970957lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3970957lifeskim:mentionsumls-concept:C0023820lld:lifeskim
pubmed-article:3970957lifeskim:mentionsumls-concept:C0041004lld:lifeskim
pubmed-article:3970957lifeskim:mentionsumls-concept:C0444669lld:lifeskim
pubmed-article:3970957lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:3970957lifeskim:mentionsumls-concept:C0014020lld:lifeskim
pubmed-article:3970957lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:3970957lifeskim:mentionsumls-concept:C2004457lld:lifeskim
pubmed-article:3970957pubmed:issue2lld:pubmed
pubmed-article:3970957pubmed:dateCreated1985-4-8lld:pubmed
pubmed-article:3970957pubmed:abstractTextTo determine whether an apolipoprotein-free artificial triacylglycerol emulsion can substitute for VLDL in studying cholesterol ester-triacylglycerol exchange processes between triacylglycerol-rich lipoproteins and cholesterol ester-rich lipoproteins, we used Intralipid to modify human plasma LDL. Intralipid was incubated with LDL in the presence of lipoprotein-poor plasma (d greater than 1.21 g/ml) at 37 degrees C. Intralipid served as an acceptor for cholesterol ester and as a donor of triacylglycerol, modifying the low-density lipoproteins so that triacylglycerol became the major core lipid in the particle - the contribution of cholesterol ester to LDL mass decreased from 38% to 18%, while that of triacylglycerol increased from 4.9% to 26%. On lipolysis most added LDL triacylglycerol (59-72%) was hydrolyzed, resulting in a smaller particle than the "native' LDL particle with net loss of cholesterol ester. Incubation of LDL with the original Intralipid emulsion resulted in modified LDL with a high relative weight of phospholipid (27.7%). On removal of excess phospholipid from Intralipid and incubation of the resultant "washed' Intralipid with LDL, the relative weight of phospholipid in modified LDL decreased to 20%, which was similar to that observed after incubation of LDL with VLDL. We demonstrate that artificial triacylglycerol emulsion can indeed substitute for VLDL in neutral lipid exchange processes, and further confirm that transfer of core cholesterol ester and triacylglycerol occurs independently of the apolipoproteins present in triacylglycerol-rich lipoproteins and LDL.lld:pubmed
pubmed-article:3970957pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3970957pubmed:languageenglld:pubmed
pubmed-article:3970957pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3970957pubmed:citationSubsetIMlld:pubmed
pubmed-article:3970957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3970957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3970957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3970957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3970957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3970957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3970957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3970957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3970957pubmed:statusMEDLINElld:pubmed
pubmed-article:3970957pubmed:monthFeblld:pubmed
pubmed-article:3970957pubmed:issn0006-3002lld:pubmed
pubmed-article:3970957pubmed:authorpubmed-author:EisenbergSSlld:pubmed
pubmed-article:3970957pubmed:authorpubmed-author:DeckelbaumR...lld:pubmed
pubmed-article:3970957pubmed:authorpubmed-author:GranotEElld:pubmed
pubmed-article:3970957pubmed:authorpubmed-author:Bengtsson-Oli...lld:pubmed
pubmed-article:3970957pubmed:authorpubmed-author:OschryYYlld:pubmed
pubmed-article:3970957pubmed:issnTypePrintlld:pubmed
pubmed-article:3970957pubmed:day8lld:pubmed
pubmed-article:3970957pubmed:volume833lld:pubmed
pubmed-article:3970957pubmed:ownerNLMlld:pubmed
pubmed-article:3970957pubmed:authorsCompleteYlld:pubmed
pubmed-article:3970957pubmed:pagination308-15lld:pubmed
pubmed-article:3970957pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:meshHeadingpubmed-meshheading:3970957-...lld:pubmed
pubmed-article:3970957pubmed:year1985lld:pubmed
pubmed-article:3970957pubmed:articleTitleCore modification of human low-density lipoprotein by artificial triacylglycerol emulsion.lld:pubmed
pubmed-article:3970957pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3970957pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3970957pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3970957pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:3970957pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3970957lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3970957lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3970957lld:pubmed